Recommendation ID
NG202/2
Question

What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing moderate and severe OSAHS?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS .

Full details of the evidence and the committee's discussion are in evidence review F: positive airway pressure therapy variants for OSAHS, OHS and COPD–OSAHS overlap syndrome.


Source guidance details

Comes from guidance
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
Number
NG202
Date issued
August 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/08/2021